💊 NCLEX-RN Exam Prep

A client with end-stage renal disease (ESRD) is receiving epoetin alfa. Which laboratory result indicates the medication is having its desired therapeutic effect?

A Serum creatinine decreased from 4.2 to 3.5 mg/dL.
B Hemoglobin increased from 8.0 to 11.5 g/dL.
C Serum potassium level 5.8 mEq/L.
D Blood urea nitrogen (BUN) decreased from 60 to 45 mg/dL.

✓ Correct Answer: Option B

Epoetin alfa stimulates red blood cell production. An increase in hemoglobin levels indicates that the medication is effectively treating the anemia commonly associated with end-stage renal disease, which is its primary therapeutic goal.

Related NCLEX-RN Exam Prep Questions